MOSCHELLA, MARIA GAETANA
 Distribuzione geografica
Continente #
EU - Europa 357
NA - Nord America 96
AS - Asia 77
SA - Sud America 4
OC - Oceania 1
Totale 535
Nazione #
IT - Italia 204
US - Stati Uniti d'America 95
DE - Germania 59
CN - Cina 20
FR - Francia 17
HK - Hong Kong 16
IN - India 14
SE - Svezia 14
ES - Italia 13
FI - Finlandia 13
SG - Singapore 12
GB - Regno Unito 11
BE - Belgio 9
JP - Giappone 6
IE - Irlanda 5
CH - Svizzera 4
CL - Cile 4
KR - Corea 4
NL - Olanda 3
GR - Grecia 2
MO - Macao, regione amministrativa speciale della Cina 2
UA - Ucraina 2
BD - Bangladesh 1
CA - Canada 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
TH - Thailandia 1
TW - Taiwan 1
Totale 535
Città #
Frankfurt am Main 44
Modena 39
New York 24
Bologna 17
Helsinki 13
Nyköping 13
Formigine 12
Hong Kong 12
Ashburn 11
Shanghai 9
Padova 8
Parma 8
Reggio Emilia 8
Argenta 7
Chandler 7
Leuven 7
Washington 7
Barcelona 6
Rossdorf 6
Singapore 6
Dublin 5
Paris 5
Piacenza 5
Rome 5
Seattle 5
Boston 4
Chennai 4
Ispra 4
Santiago 4
Zurich 4
Brescello 3
Brescia 3
Coimbatore 3
Cornellà de Llobregat 3
Courbevoie 3
Dundee 3
London 3
Loreto 3
Madrid 3
Marseille 3
Perugia 3
Tokyo 3
Varanasi 3
Aberdeen 2
Amsterdam 2
Beijing 2
Brussels 2
Buckie 2
Carpi 2
Castelfranco Emilia 2
Castelleone 2
Chongqing 2
Dallas 2
Guwahati 2
Houston 2
Imola 2
Kavala 2
Legnano 2
Milan 2
Montecarlo 2
Osnabrück 2
Porretta Terme 2
Raleigh 2
Reims 2
Romainville 2
San Cesario sul Panaro 2
San Diego 2
Sant'Ilario d'Enza 2
Scandiano 2
Sciacca 2
Turin 2
Vicenza 2
Vignola 2
Villafranca di Verona 2
Vimercate 2
Visakhapatnam 2
Albese Con Cassano 1
Bagnolo in Piano 1
Bangkok 1
Bari 1
Belmont 1
Boardman 1
Bremen 1
Busana 1
Capriolo 1
Chiyoda-ku 1
Coria del Río 1
Dunedin 1
Eunpyeong-gu 1
Ferrara 1
Gwanak-gu 1
Los Angeles 1
Markham 1
Medesano 1
Nijmegen 1
Oslo 1
Ravenna 1
Roquefort-la-Bedoule 1
Sale 1
Salerno 1
Totale 438
Nome #
LC-MS serum proteomics reveals a panel of proteins prognostic of positive responsiveness to bevacizumab therapy in late-stages ovarian cancer patients 79
Development of a novel class of YAP:TEAD interface-3 molecular disruptors to treat colorectal carcinoma 69
A toolbox of biophysical and analytical assays helps to confirm the activity of novel hTS dimer disrupters (Ddis) with anticancer properties 61
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth 55
Applying optical tweezers technology to reveal Thymidylate Synthase interactions with its consensus mRNA 49
design, synthesis and biological evaluation of novel YAP:TEAD complex disruptors for thetreatment of colorectal cancer 49
Targeting the dimer-monomer equilibrium of thymidylate synthase, to accelerate protein degradation and cancer cell growth inhibition 46
Lead-optimization process and characterization of the dissociative effect applied to new dimer disrupters of human Thymidylate Synthase 40
Development of a sensitive biochemical tool to assess the expression levels of recombinant ectopic proteins in in vitro engineered cellular systems 35
Lead optimization of human thymidylate synthase dimer disrupters: from computational studies to evaluation of their biological profiles 25
Exploiting the Optical Tweezer technology to reveal thymidylate synthase interactions with its consensus mRNA 25
Precision medicine through proteomics studies in drug resistant colorectal cancer 11
EXPLOITING THE OPTICAL TWEEZER, A SINGLE MOLECULE TECHNOLOGY, TO REVEAL THYMIDYLATE SYNTHASE INTERACTIONS WITH ITS CONSENSUS mRNA 2
Totale 546
Categoria #
all - tutte 2.958
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.958


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023174 2 5 7 13 13 14 29 15 25 15 21 15
2023/2024372 31 48 39 27 120 29 23 23 16 16 0 0
Totale 546